|Mr. Andrew J. Hykes||CEO, Pres & Director||863.78k||800.42k||1974|
|Mr. Mitchell C. Hill||Chief Financial Officer||811.08k||5.86M||1959|
|Dr. Thomas M. Tu M.D.||Chief Medical Officer||812.94k||2.85M||1973|
|Mr. Paul A. Koehn||Sr. VP of Operations||N/A||N/A||1963|
|Mr. John Hsu C.F.A.||VP of Investor Relations||N/A||N/A||N/A|
|Ms. Angela Ahmad||Gen. Counsel & Sec.||N/A||N/A||N/A|
|Mr. Eric Khairy||Sr. VP of Marketing||N/A||N/A||N/A|
|Mr. John R. Borrell||Sr. VP of Sales||N/A||N/A||1967|
|Ms. Tara Dunn||Sr. VP of Clinical Affairs & Market Devel.||N/A||N/A||N/A|
|Mr. Brian Strauss||Sr. VP of Engineering||N/A||N/A||N/A|
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Inari Medical, Inc.’s ISS governance QualityScore as of 1 September 2023 is 6. The pillar scores are Audit: 2; Board: 6; Shareholder rights: 8; Compensation: 6.